These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
246 related articles for article (PubMed ID: 37337034)
41. Low-dose radiotherapy promotes the formation of tertiary lymphoid structures in lung adenocarcinoma. Wang D; Huang L; Qian D; Cao Y; Wu X; Xu P; Ming L; Tang J; Huang Z; Yin Y; Zhou L Front Immunol; 2023; 14():1334408. PubMed ID: 38259481 [TBL] [Abstract][Full Text] [Related]
42. The distribution and maturation of tertiary lymphoid structures can predict clinical outcomes of patients with gastric adenocarcinoma. Sun H; Liu Y; Cheng W; Xiong R; Gu W; Zhang X; Wang X; Wang X; Tan C; Weng W; Zhang M; Ni S; Huang D; Xu M; Sheng W; Wang L Front Immunol; 2024; 15():1396808. PubMed ID: 39136032 [TBL] [Abstract][Full Text] [Related]
43. Tertiary lymphoid structure patterns aid in identification of tumor microenvironment infiltration and selection of therapeutic agents in bladder cancer. An Y; Sun JX; Xu MY; Xu JZ; Ma SY; Liu CQ; Liu Z; Wang SG; Xia QD Front Immunol; 2022; 13():1049884. PubMed ID: 36420257 [TBL] [Abstract][Full Text] [Related]
44. Tertiary lymphoid structures: Associated multiple immune cells and analysis their formation in hepatocellular carcinoma. Nie Y; Fan H; Li J; Lei X; Zhang T; Wang Y; Mao Z; Tao K; Song W FASEB J; 2022 Nov; 36(11):e22586. PubMed ID: 36190431 [TBL] [Abstract][Full Text] [Related]
45. Tertiary lymphoid structures are associated with favorable survival outcomes in patients with endometrial cancer. Qin M; Hamanishi J; Ukita M; Yamanoi K; Takamatsu S; Abiko K; Murakami R; Miyamoto T; Suzuki H; Ueda A; Hosoe Y; Horie A; Yamaguchi K; Mandai M Cancer Immunol Immunother; 2022 Jun; 71(6):1431-1442. PubMed ID: 34689225 [TBL] [Abstract][Full Text] [Related]
46. Tertiary lymphoid structures as unique constructions associated with the organization, education, and function of tumor-infiltrating immunocytes. Chen J; Chen J; Wang L J Zhejiang Univ Sci B; 2022 Oct; 23(10):812-822. PubMed ID: 36226536 [TBL] [Abstract][Full Text] [Related]
47. Immune cells within tertiary lymphoid structures are associated with progression-free survival in patients with locoregional recurrent breast cancer. Gu J; Wang J; Sun Y; Mao X; Qian C; Tang X; Wang J; Xie H; Ling L; Zhao Y; Liu X; Zhang K; Pan H; Wang S; Wang C; Zhou W Cancer Med; 2024 Jan; 13(1):e6864. PubMed ID: 38133211 [TBL] [Abstract][Full Text] [Related]
48. Characterization of intratumoral tertiary lymphoid structures in pancreatic ductal adenocarcinoma: cellular properties and prognostic significance. Zou X; Lin X; Cheng H; Chen Y; Wang R; Ma M; Liu Y; Dai Z; Tasiheng Y; Yan Y; Hou Q; Ding F; Chen H; Yu X; Wang X; Liu C J Immunother Cancer; 2023 Jun; 11(6):. PubMed ID: 37364934 [TBL] [Abstract][Full Text] [Related]
49. The association of immune cell infiltration and prognostic value of tertiary lymphoid structures in gastric cancer. Yu JS; Huang WB; Zhang YH; Chen J; Li J; Fu HF; Wei ZW; He YL Neoplasma; 2022 Jul; 69(4):886-898. PubMed ID: 35603954 [TBL] [Abstract][Full Text] [Related]
50. Tertiary lymphoid structures combined with biomarkers of inflammation are associated with the efficacy of neoadjuvant immunochemotherapy in resectable non-small cell lung cancer: A retrospective study. Xu F; Zhu H; Xiong D; Wang K; Dong Y; Li L; Yuan S Thorac Cancer; 2024 Jan; 15(2):172-181. PubMed ID: 38057283 [TBL] [Abstract][Full Text] [Related]
52. Triple-negative breast cancer survival prediction using artificial intelligence through integrated analysis of tertiary lymphoid structures and tumor budding. Hou X; Li X; Han Y; Xu H; Xie Y; Zhou T; Xue T; Qian X; Li J; Wang HC; Yan J; Guo X; Liu Y; Liu J Cancer; 2024 Apr; 130(S8):1499-1512. PubMed ID: 38422056 [TBL] [Abstract][Full Text] [Related]
53. Tertiary lymphoid structures in lung adenocarcinoma: characteristics and related factors. Ren F; Xie M; Gao J; Wu C; Xu Y; Zang X; Ma X; Deng H; Song J; Huang A; Pang L; Qian J; Yu Z; Zhuang G; Liu S; Pan L; Xue X Cancer Med; 2022 Aug; 11(15):2969-2977. PubMed ID: 35801360 [TBL] [Abstract][Full Text] [Related]
54. B cells and tertiary lymphoid structures are associated with survival in papillary thyroid cancer. Li YY; Li SJ; Liu MC; Chen Z; Li L; Shen F; Liu QZ; Xu B; Lian ZX J Endocrinol Invest; 2023 Nov; 46(11):2247-2256. PubMed ID: 37004696 [TBL] [Abstract][Full Text] [Related]
55. Helper T cell-dominant tertiary lymphoid structures are associated with disease relapse of advanced colorectal cancer. Yamaguchi K; Ito M; Ohmura H; Hanamura F; Nakano M; Tsuchihashi K; Nagai S; Ariyama H; Kusaba H; Yamamoto H; Oda Y; Nakamura M; Akashi K; Baba E Oncoimmunology; 2020; 9(1):1724763. PubMed ID: 32117589 [TBL] [Abstract][Full Text] [Related]
56. Mapping the complexity and diversity of tertiary lymphoid structures in primary and peritoneal metastatic gastric cancer. Groen-van Schooten TS; Franco Fernandez R; van Grieken NCT; Bos EN; Seidel J; Saris J; Martínez-Ciarpaglini C; Fleitas TC; Thommen DS; de Gruijl TD; Grootjans J; Derks S J Immunother Cancer; 2024 Jul; 12(7):. PubMed ID: 38955417 [TBL] [Abstract][Full Text] [Related]
57. Prognostic value of tertiary lymphoid structures in hepatocellular carcinoma: a meta-analysis and systematic review. Hu L; Li X; Yang C; Zhou B; Du C; Jiang N Front Immunol; 2024; 15():1390938. PubMed ID: 38887293 [TBL] [Abstract][Full Text] [Related]
58. CCL19-producing fibroblasts promote tertiary lymphoid structure formation enhancing anti-tumor IgG response in colorectal cancer liver metastasis. Zhang Y; Liu G; Zeng Q; Wu W; Lei K; Zhang C; Tang M; Zhang Y; Xiang X; Tan L; Cui R; Qin S; Song X; Yin C; Chen Z; Kuang M Cancer Cell; 2024 Aug; 42(8):1370-1385.e9. PubMed ID: 39137726 [TBL] [Abstract][Full Text] [Related]
59. Tumor-Resident T Cells, Associated With Tertiary Lymphoid Structure Maturity, Improve Survival in Patients With Stage III Lung Adenocarcinoma. Zhao H; Wang H; Zhao Y; Sun Q; Ren X Front Immunol; 2022; 13():877689. PubMed ID: 35663939 [TBL] [Abstract][Full Text] [Related]
60. Germinal Centers Determine the Prognostic Relevance of Tertiary Lymphoid Structures and Are Impaired by Corticosteroids in Lung Squamous Cell Carcinoma. Siliņa K; Soltermann A; Attar FM; Casanova R; Uckeley ZM; Thut H; Wandres M; Isajevs S; Cheng P; Curioni-Fontecedro A; Foukas P; Levesque MP; Moch H; Linē A; van den Broek M Cancer Res; 2018 Mar; 78(5):1308-1320. PubMed ID: 29279354 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]